Bioventix PLC Sustainability Reports
Bioventix PLC specializes in the development and commercial supply of high-affinity sheep monoclonal antibodies (SMAs) for use in clinical diagnostics blood testing. Its portfolio includes antibodies targeting heart disease, cancer, fertility, and thyroid conditions.
Sector: Professional & technical services
Country: United Kingdom
Exchange: London Stock Exchange (AIM)
ISIN: GB00B4QVDF07
7 reports from 2019 to 2025